Skip to main content

Table 3 Changes in blood glucose, plasma insulin, ISI and serum lipid profiles in T2DM rats

From: Endogenous asymmetric dimethylarginine accumulation contributes to the suppression of myocardial mitochondrial biogenesis in type 2 diabetic rats

Groups FBG
(mmol/L)
FIns
(mU/L)
ISI
(×10−3)
TG
(mmol/L)
TC
(mmol/L)
LDL-C
(mmol/L)
HDL-C
(mmol/L)
Control 7.00 ±  0.28 33.17 ±  4.01 4.80 ± 0.69 0.60 ±  0.02 1.25 ± 0.17 0.67 ± 0.11 0.47 ± 0.03
T2DM 20.74 ± 2.32** 68.73 ± 5.33** 0.83 ± 0.14** 2.98 ± 0.19** 3.13 ± 0.43** 2.64 ± 0.16** 0.34 ± 0.02**
  1. Levels of fasting blood glucose (FBG), fasting plasma insulin (FIns) and lipid profiles in serum including triglyceride (TG), total cholesterol (TC), low density lipoprotein-cholesterol (LDL-C) and high density lipoprotein-cholesterol (HDL-C) were assayed spectrophotometrically with respective commercial kits in control and type 2 diabetic (T2DM) rats. Insulin sensitivity index (ISI) was calculated with FBG and FIns (ISI = 1/FBG × FIns). Data are expressed as mean ± S.E.M.; n = 5. **P < 0.01 vs Control